phase iii clinical trials – Spanish Translation – Keybot Dictionary
TTN Translation Network
TTN
TTN
Login
Deutsch
Français
Source Languages
Target Languages
Select
Select
Keybot
13
Results
8
Domains
6 Hits
www.biocat.cat
Show text
Show cached source
Open source URL
This Catalan biotech firm has already initiated
Phase III clinical trials
on Lutrate Depot ® 3 month in the United States.
Compare text pages
Compare HTM pages
Open source URL
Open target URL
Define
biocat.cat
as primary domain
La biotecnológica catalana ya ha iniciado el ensayo clínico Fase III de Lutrate Depot® en administración trimestral, en Estados Unidos.
blog.hospitalclinic.org
Show text
Show cached source
Open source URL
With these promising results for the curation of hepatitis C with only 12 weeks of treatment and a very good tolerance, several
phase III clinical trials
have been launched that will evaluate the effectiveness of this therapeutic approach in a higher number of patients.
Compare text pages
Compare HTM pages
Open source URL
Open target URL
Define
blog.hospitalclinic.org
as primary domain
Con estos prometedores resultados de curación de la hepatitis con tan sólo 12 semanas de tratamiento y con una tolerancia muy buena, ya se han puesto en marcha diferentes ensayos clínicos en fase III que evaluarán la eficacia de esta pauta terapéutica en un número mayor de pacientes.
tulaparking.ru
Show text
Show cached source
Open source URL
We included
phase III clinical trials
that used bevacizumab alone or in combination with chemotherapy as for MBC or locally recurrent. Statistical analyses were conducted to calculate summary odds ratio (OR) of the eight most relevant adverse outcomes related with bevacizumab.
Compare text pages
Compare HTM pages
Open source URL
Open target URL
Define
mdanderson.es
as primary domain
Bevacizumab is a monoclonal antibody against vascular endothelial growth factor with the ability to increase progression-free survival in metastatic breast cancer (MBC). A systematic review and meta-analysis was conducted to determine the risk of the most clinically relevant adverse outcomes associated with the use of bevacizumab in the treatment of breast cancer.
sensiseeds.com
Show text
Show cached source
Open source URL
, which contains an almost equal proportion of THC and CBD, is approved at present in the United Kingdom and several European countries for treating spasticity caused by multiple sclerosis (MS) and for pain relief in patients with cancer, and is currently undergoing
phase III clinical trials
in the US.
Compare text pages
Compare HTM pages
Open source URL
Open target URL
Define
sensiseeds.com
as primary domain
, que contiene una proporción casi igual de THC y CBD, está aprobado en la actualidad en el Reino Unido y en varios países de Europa para tratar la espasticidad causada por la esclerosis múltiple (EM) y para tratar el dolor en pacientes con cáncer, y hoy se encuentra en la fase III de ensayos clínicos en los EE.UU.
contest.agorapulse.com
Show text
Show cached source
Open source URL
If E1224 progresses successfully through
Phase III clinical trials
, it could become one of the first new treatments for Chagas disease in 40 years. The only current treatment options – nifurtimox and benznidazole – are known to have serious limitations in adult chronic patients, from allergies to potentially serious peripheral and central nervous system reactions, and their efficacy diminishes the longer the patient has been infected.
Compare text pages
Compare HTM pages
Open source URL
Open target URL
Define
dndi.org
as primary domain
La enfermedad de Chagas es una infección crónica, sistémica y parasitaria causada por el protozoario Trypanosoma cruzi. En el 30-40% de los casos, la enfermedad crónica de Chagas afecta al corazón y/o al sistema digestivo. Es potencialmente mortal y la causa principal de insuficiencia cardíaca, dando lugar a hospitalizaciones frecuentes y prolongadas, al uso de marcapasos y desfibriladores y transplantes de corazón. La enfermedad deja a decenas de miles de jóvenes, adultos en edad laboral en los hospitales de toda América Latina lo que causa más de mil millones de dólares en pérdidas económicas anuales.